T2 Biosystems Inc. [NASDAQ: TTOO] slipped around -0.2 points on Thursday, while shares priced at $1.31 at the close of the session, down -13.25%. The company report on November 5, 2020 that T2 Biosystems Announces Third Quarter 2020 Financial Results.
Total revenues increase by 213% on record high quarterly product sales.
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced financial results for the third quarter ended September 30, 2020.
T2 Biosystems Inc. stock is now 11.97% up from its year-to-date (YTD) trading value. TTOO Stock saw the intraday high of $1.39 and lowest of $1.27 per share. The company’s 52-week high price is 3.00, which means current price is +457.45% above from all time high which was touched on 07/01/20.
Compared to the average trading volume of 6.24M shares, TTOO reached a trading volume of 8438388 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about T2 Biosystems Inc. [TTOO]?
BTIG Research have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 08, 2020. The new note on the price target was released on November 26, 2019, representing the official price target for T2 Biosystems Inc. stock.
The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.09, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 19.63.
How has TTOO stock performed recently?
T2 Biosystems Inc. [TTOO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.50. With this latest performance, TTOO shares gained by 0.77% in over the last four-week period, additionally plugging by 155.51% over the last 6 months – not to mention a drop of -51.84% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 47.99, with the RSI for the last a single of trading hit 46.15, and the three-weeks RSI is set at 47.88 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 1.3278, while it was recorded at 1.3660 for the last single week of trading, and 1.0853 for the last 200 days.
T2 Biosystems Inc. [TTOO]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and T2 Biosystems Inc. [TTOO] shares currently have an operating margin of -624.57 and a Gross Margin at -101.12. T2 Biosystems Inc.’s Net Margin is presently recorded at -707.93.
Additionally, TTOO Total Debt to Total Capital is recorded at 366.64, with Total Debt to Total Assets ending up at 164.14.
Reflecting on the efficiency of the workforce at the company, T2 Biosystems Inc. [TTOO] managed to generate an average of -$390,768 per employee. Receivables Turnover for the company is 3.62 with a Total Asset Turnover recorded at a value of 0.18.T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.40 and a Current Ratio set at 6.00.
Earnings analysis for T2 Biosystems Inc. [TTOO]
With the latest financial reports released by the company, T2 Biosystems Inc. posted -0.29/share EPS, while the average EPS was predicted by analysts to be reported at -0.27/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -7.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TTOO.
Insider trade positions for T2 Biosystems Inc. [TTOO]
There are presently around $20 million, or 10.10% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 4,759,684, which is approximately 115.143% of the company’s market cap and around 5.94% of the total institutional ownership; GOLDMAN SACHS GROUP INC, holding 4,358,817 shares of the stock with an approximate value of $5.71 million in TTOO stocks shares; and BLACKROCK INC., currently with $2.15 million in TTOO stock with ownership of nearly 59.267% of the company’s market capitalization.
Positions in T2 Biosystems Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 27 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 5,197,986 shares. Additionally, 20 investors decreased positions by around 1,302,016 shares, while 16 investors held positions by with 8,879,337 shares. The mentioned changes placed institutional holdings at 15,379,339 shares, according to the latest SEC report filing. TTOO stock had 17 new institutional investments in for a total of 1,591,827 shares, while 9 institutional investors sold positions of 541,276 shares during the same period.